These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

767 related items for PubMed ID: 28931080

  • 1. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY, Wu SX.
    PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression.
    Gao YT, Chen XB, Liu HL.
    Sci Rep; 2016 Sep 06; 6():32972. PubMed ID: 27595933
    [Abstract] [Full Text] [Related]

  • 3. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients.
    Yuan GQ, Wei NL, Mu LY, Wang XQ, Zhang YN, Zhou WN, Pan YW.
    Cancer Biomark; 2017 Dec 06; 20(4):443-452. PubMed ID: 28869437
    [Abstract] [Full Text] [Related]

  • 4. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
    Chen J, Yang L, Wang X.
    Cancer Biomark; 2017 Dec 06; 20(4):521-526. PubMed ID: 28946553
    [Abstract] [Full Text] [Related]

  • 5. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
    Zhang H, Wang J, Wang Z, Ruan C, Wang L, Guo H.
    Cancer Biomark; 2019 Dec 06; 24(1):43-49. PubMed ID: 30530966
    [Abstract] [Full Text] [Related]

  • 6. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
    Cheng W, Ren X, Cai J, Zhang C, Li M, Wang K, Liu Y, Han S, Wu A.
    Oncotarget; 2015 Oct 06; 6(30):29285-95. PubMed ID: 26320189
    [Abstract] [Full Text] [Related]

  • 7. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.
    Sana J, Radova L, Lakomy R, Kren L, Fadrus P, Smrcka M, Besse A, Nekvindova J, Hermanova M, Jancalek R, Svoboda M, Hajduch M, Slampa P, Vyzula R, Slaby O.
    Carcinogenesis; 2014 Dec 06; 35(12):2756-62. PubMed ID: 25322872
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J.
    J Neurosurg; 2016 Jan 06; 124(1):122-8. PubMed ID: 26230475
    [Abstract] [Full Text] [Related]

  • 9. MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: An integrated bioinformatics and experimental study.
    Rahmati Y, Alivand M, Mollanoori H.
    Comput Biol Chem; 2021 Jun 06; 92():107458. PubMed ID: 33761401
    [Abstract] [Full Text] [Related]

  • 10. miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma.
    Cheng ZX, Song YX, Wang ZY, Wang Y, Dong Y.
    Eur Rev Med Pharmacol Sci; 2017 Sep 06; 21(18):4079-4086. PubMed ID: 29028093
    [Abstract] [Full Text] [Related]

  • 11. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
    Kerimis D, Kontos CK, Christodoulou S, Papadopoulos IN, Scorilas A.
    Clin Biochem; 2017 Apr 06; 50(6):285-292. PubMed ID: 27939727
    [Abstract] [Full Text] [Related]

  • 12. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L, Chu F, Cao Y, Shao J, Wang F.
    Tumour Biol; 2015 Sep 06; 36(10):7439-47. PubMed ID: 25903466
    [Abstract] [Full Text] [Related]

  • 13. Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform.
    Swellam M, Ezz El Arab L, Al-Posttany AS, B Said S.
    J Neurooncol; 2019 Sep 06; 144(3):545-551. PubMed ID: 31422498
    [Abstract] [Full Text] [Related]

  • 14. Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients.
    Shahar T, Granit A, Zrihan D, Canello T, Charbit H, Einstein O, Rozovski U, Elgavish S, Ram Z, Siegal T, Lavon I.
    J Neurooncol; 2016 Dec 06; 130(3):413-422. PubMed ID: 27573219
    [Abstract] [Full Text] [Related]

  • 15. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients.
    Salvati M, Pichierri A, Piccirilli M, Floriana Brunetto GM, D'Elia A, Artizzu S, Santoro F, Arcella A, Giangaspero F, Frati A, Simione L, Santoro A.
    J Neurosurg; 2012 Aug 06; 117(2):204-11. PubMed ID: 22655594
    [Abstract] [Full Text] [Related]

  • 16. miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma.
    Khalil S, Fabbri E, Santangelo A, Bezzerri V, Cantù C, Di Gennaro G, Finotti A, Ghimenton C, Eccher A, Dechecchi M, Scarpa A, Hirshman B, Chen C, Ferracin M, Negrini M, Gambari R, Cabrini G.
    Oncotarget; 2016 May 10; 7(19):28195-206. PubMed ID: 27057640
    [Abstract] [Full Text] [Related]

  • 17. Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin.
    Herman A, Gruden K, Blejec A, Podpečan V, Motaln H, Rožman P, Hren M, Zupančič K, Veber M, Verbovšek U, Lah Turnšek T, Porčnik A, Koršič M, Knežević M, Jeras M.
    PLoS One; 2015 May 10; 10(5):e0125791. PubMed ID: 25950799
    [Abstract] [Full Text] [Related]

  • 18. MiR-106a is an independent prognostic marker in patients with glioblastoma.
    Zhao S, Yang G, Mu Y, Han D, Shi C, Chen X, Deng Y, Zhang D, Wang L, Liu Y, Hou X, Wang C, Wu J, Liu H, Wang L, Zhang G, Qi J, Fang X, Shi C, Ai J.
    Neuro Oncol; 2013 Jun 10; 15(6):707-17. PubMed ID: 23416698
    [Abstract] [Full Text] [Related]

  • 19. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool.
    Manterola L, Guruceaga E, Gállego Pérez-Larraya J, González-Huarriz M, Jauregui P, Tejada S, Diez-Valle R, Segura V, Samprón N, Barrena C, Ruiz I, Agirre A, Ayuso A, Rodríguez J, González A, Xipell E, Matheu A, López de Munain A, Tuñón T, Zazpe I, García-Foncillas J, Paris S, Delattre JY, Alonso MM.
    Neuro Oncol; 2014 Apr 10; 16(4):520-7. PubMed ID: 24435880
    [Abstract] [Full Text] [Related]

  • 20. The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients' survival: a meta-analysis.
    Zhao H, Wang S, Song C, Zha Y, Li L.
    World J Surg Oncol; 2016 Oct 12; 14(1):261. PubMed ID: 27733166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.